NAS:OPT (Australia)  
Opthea Ltd logo

Opthea Ltd

$ 6.00 -0.13 (-2.12%) 10:08 PM EST
P/E:
At Loss
P/B:
5.70
Market Cap:
$ 297.52M
Enterprise V:
$ 205.54M
Volume:
15.14K
Avg Vol (2M):
4.12K
Also Trade In:
Volume:
15.14K
Market Cap $:
297.52M
PE Ratio:
At Loss
Avg Vol (2-Month):
4.12K
Enterprise Value $:
205.54M
PB Ratio:
5.70
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.8
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.44
Distress
Grey
Safe
Beneish M-Score -6.08
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.14
9-Day RSI 47.96
14-Day RSI 46.69
6-1 Month Momentum % -5.69
12-1 Month Momentum % -26.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.97
Quick Ratio 4.97
Cash Ratio 3.71
Days Sales Outstanding 2207.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.2

Financials (Next Earnings Date:2023-02-28 Est.)

OPT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OPT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.09
EPS (TTM) ($) -2.112
Beta 0.27
Volatility % 56.05
14-Day RSI 46.69
14-Day ATR ($) 0.205877
20-Day SMA ($) 5.987045
12-1 Month Momentum % -26.8
52-Week Range ($) 4.7344 - 8.5
Shares Outstanding (Mil) 50.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Opthea Ltd Filings

Document Form Filing Date
No Filing Data

Opthea Ltd Analysis

Share your research

Headlines

See More
No news.